SCHEMBL20026432

SCHEMBL20026432

COc1cc2sccc2c(F)c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 5/20 0.44
TUBB P07437 5/20 0.44
TUBA3C P0DPH7 5/20 0.44
TUBA1B P68363 5/20 0.44
TUBA4A P68366 5/20 0.44
TUBB4B P68371 5/20 0.44
TUBB3 Q13509 5/20 0.44
TUBB2A Q13885 5/20 0.44
TUBB8 Q3ZCM7 5/20 0.44
TUBA3E Q6PEY2 5/20 0.44
TUBA1A Q71U36 5/20 0.44
TUBA1C Q9BQE3 5/20 0.44
TUBB6 Q9BUF5 5/20 0.44
TUBB2B Q9BVA1 5/20 0.44
TUBB1 Q9H4B7 5/20 0.44
STING1 Q86WV6 6/20 0.44
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
KEAP1 Q14145 1/20 0.37
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29636412 1.00 TUBB4A (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL16010332 0.84 TUBB4A (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL24175669 0.79 TUBB4A (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5687768 0.72 TUBB1 (0.60) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5689307 0.72 TUBB1 (0.60) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5687761 0.72 TUBB1 (0.60) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL10372067 0.71 SLC6A2 (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3480388 0.71 MAPT (0.34) MAPTTSHR
SCHEMBL5758557 0.69 MAPT (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4803640 0.69 SLC6A2 (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536672-A1 STING AGONIST COMPOUNDS Sutro Biopharma, Inc. (US) 2025-04-16 EP disclosed
WO-2023239675-A1 STING AGONIST COMPOUNDS SUTRO BIOPHARMA, INC. (US) 2023-12-14 WO disclosed
WO-2023239675-A1 STING AGONIST COMPOUNDS SUTRO BIOPHARMA, INC. (US) 2023-12-14 WO disclosed
CN-110036001-B Benzo [ b ] thiophene compounds as STING agonists 默沙东公司 2022-03-22 CN disclosed
WO-2022002077-A1 ARYL AROMATIC HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海海和药物研究开发股份有限公司 2022-01-06 WO disclosed
US-10793557-B2 Sting agonist compounds MERCK SHARP & DOHME CORP. (US) 2020-10-06 US disclosed
US-10730849-B2 Benzo[b]thiophene compounds as STING agonists MERCK SHARP & DOHME CORP. (US) 2020-08-04 US disclosed
US-10703738-B2 Benzo[b]thiophene compounds as STING agonists MERCK SHARP & DOHME CORP. (US) 2020-07-07 US disclosed
US-20190337917-A1 BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2019-11-07 US disclosed
WO-2019195124-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2019-10-10 WO disclosed
US-20190300513-A1 STING AGONIST COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2019-10-03 US disclosed
US-10414747-B2 Benzo[b]thiophene compounds as sting agonists MERCK SHARP & DOHME CORP. (US) 2019-09-17 US disclosed
WO-2018067423-A1 BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-04-12 WO disclosed
US-20180093964-A1 BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300513-A1 STING AGONIST COMPOUNDS STING1, CGAS, IRF3 TUBB4A 3502/4885TUBB 3958/4885TUBA3C 4613/4885
US-10730849-B2 Benzo[b]thiophene compounds as STING agonists STING1, IRF3, CGAS TUBB4A 3145/4885TUBB 3006/4885TUBA3C 4019/4885
US-20180093964-A1 BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS STING1, IRF3, CGAS TUBB4A 3145/4885TUBB 3006/4885TUBA3C 4019/4885
US-10793557-B2 Sting agonist compounds STING1, CGAS, IRF3 TUBB4A 3502/4885TUBB 3958/4885TUBA3C 4613/4885
US-10414747-B2 Benzo[b]thiophene compounds as sting agonists STING1, IRF3, CGAS TUBB4A 3145/4885TUBB 3006/4885TUBA3C 4019/4885
US-20190337917-A1 BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS STING1, IRF3, CGAS TUBB4A 3145/4885TUBB 3006/4885TUBA3C 4019/4885
US-10703738-B2 Benzo[b]thiophene compounds as STING agonists STING1, IRF3, CGAS TUBB4A 3145/4885TUBB 3006/4885TUBA3C 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.